
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>103-306</title>
    </head>

    <body>
        <h1>
        <a href="./103_305.html" rel="external" title="prev">≪</a>
        103-306
        <a href="./103_307.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>69歳女性。皮膚科を受診し、四肢の皮膚湿疹に対して以下の処方箋を持ち、初めてこの薬局を訪れた。薬剤師が薬を取りそろえる前にお薬手帳で併用薬を確認したところ、女性はラタノプロスト点眼液を処方されていた。</p>
<p>なお、副作用歴やアレルギー歴は無いとのことであった。女性は今回の処方薬を初めて使用する。</p>
<p><img alt="" class="alignnone size-full wp-image-3288" height="240.1" loading="lazy" sizes="(max-width: 689px) 100vw, 689px" src="data:;base64,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" width="482.29999999999995"/></p>
<h4>問306</h4>
<p>処方監査に基づく疑義照会について正しいのはどれか。2つ選べ。</p>
<ol><li>処方に誤りがあり、疑義があったにもかかわらず、薬剤師が疑義照会をせず、そのため患者に健康被害が発生した場合、処方医が損害賠償責任を負うが、薬剤師は負わない。</li><li>疑義照会は、処方医でなくても医師に行えばよい。</li><li>処方箋中に法令に定められた事項が記載されていない場合には、疑義照会を行わなければならない。</li><li>患者がお薬手帳を持参しない場合には、併用薬はないものとして疑義の有無を判断する。</li><li>疑義照会による医師からの回答の内容は処方箋に記入しなければならない。</li></ol>
<h4>問307</h4>
<p>これらの処方の疑義照会において、変更を提案すべき処方はどれか。1つ選べ。</p>
<ol><li>処方1</li><li>処方2</li><li>処方3</li><li>処方1と処方2</li><li>処方1と処方3</li><li>処方2と処方3</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問306：3, 5問307：1
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問306</h4>
<p><span style="font-weight: 400;">ラタノプロスト点眼中なので、</span><span style="font-weight: 400;">緑内障、高眼圧と考えられます。</span></p>
<p><span style="font-weight: 400;">選択肢 1 ですが<br/></span><span style="font-weight: 400;">疑義照会をせず、健康被害が発生した場合、</span><span style="font-weight: 400;">薬剤師にも損害賠償責任が生じます。</span><span style="font-weight: 400;">よって、選択肢 1 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 2 ですが<br/></span><span style="font-weight: 400;">処方医でなければ処方意図がわかりません。</span><span style="font-weight: 400;">よって、選択肢 2 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 3 は、正しい記述です。</span></p>
<p><span style="font-weight: 400;">選択肢 4 ですが<br/></span><span style="font-weight: 400;">併用薬がないものとするのではなく、</span><span style="font-weight: 400;">併用薬がないかを聞き取りにより確認し</span><span style="font-weight: 400;">疑義の有無を判断します。</span><span style="font-weight: 400;">よって、選択肢 4 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 5 は、正しい記述です。</span></p>
<p><span style="font-weight: 400;">以上より、正解は 3,5 です。</span></p>
<h4>問307</h4>
<p><span style="font-weight: 400;">緑内障患者で、</span><span style="font-weight: 400;">処方１が抗コリン作用があるため、</span><span style="font-weight: 400;">疑義照会を行い</span><span style="font-weight: 400;">エピナスチンなどへの</span><span style="font-weight: 400;">処方変更を提案すべきです。</span></p>
<p><span style="font-weight: 400;">以上より、正解は 1 です。</span></p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    